Company / Capital Expenditures
Axogen, Inc. Capital Expenditures History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Capital Expenditures
$3.7M
FY2025
5-year range
$3.1M / $21.9M
FY2021-FY2025
Trend
+20.8%
vs FY2024
Sector context
#133 of 151
Health Care
What the data says
Axogen, Inc.'s capital expenditures of $4M is lower than 88% of companies in the Health Care sector (FY2025). Capital Expenditures returned to growth in FY2025 after 2 years of decline, reaching $4M.
Based on SEC 10-K filings.
$4M in FY2025 with a 5-year CAGR of -9.8%.
Declined from $14M to $4M over the past 2 years.
Health Care sector context is included.
Capital Expenditures over time
Growth rates
- 3-Year CAGR
- -44.5%
- 5-Year CAGR
- -9.8%
- 10-Year CAGR
- -
Sector benchmark
Bottom 12% in Health CareTop 88% of 151This company $3.7M Sector average $271.7M
▼
-98.6% below sector average
Key checks
Key Insights
- 5-year CAGR of -9.8%, indicating a declining trend.
- In FY2025, capital expenditures increased 20.8% year-over-year.
- Ranks #133 out of 151 companies in the Health Care sector.
- Peak capital expenditures was recorded in FY2022.
Company context
Key Data Points
- Altman Z-Score 0.63 (distress zone, below 1.8 threshold)
- Negative profit margin: -5.3%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Capital ExpendituresValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $3.7M | +20.8% |
| FY2024 | $3.1M | -77.6% |
| FY2023 | $13.9M | -36.7% |
| FY2022 | $21.9M | +369.7% |
| FY2021 | $4.7M | -25.8% |
| FY2020 | $6.3M | +34.7% |
| FY2019 | $4.7M | +401.0% |
| FY2018 | $931.0K | -15.7% |
| FY2017 | $1.1M | +170.3% |
| FY2016 | $408.8K | +0.0% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026